About
Research
Products
Investors
Careers
Agenda
fr
Press Releases
Our latest news and press releases
All
2021
2020
2019
2018
2017
2016
11
May
2020
16:30 E.S.T.
Cellectis’ Annual Shareholders’ General Meeting to be Held on June 29, 2020
Read more
06
May
2020
16:30 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2020
Read more
29
Apr
2020
16:30 E.S.T.
Cellectis to Hold First Quarter 2020 Earnings Call on Thursday, May 7, 2020 at 7:30 AM EDT
Read more
13
Apr
2020
16:30 E.S.T.
Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer
Read more
10
Mar
2020
16:30 E.S.T.
US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted to Cellectis
Read more
04
Mar
2020
16:30 E.S.T.
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2019 Financial Results
Read more
04
Mar
2020
16:05 E.S.T.
Cellectis and Servier Execute the Amendment Confirming the Expansion of their Collaboration on UCART19 Products
Read more
25
Feb
2020
16:30 E.S.T.
Cellectis to Hold Fourth Quarter and Full Year 2019 Earnings Call on Thursday, March 5, 2020 at 7:30 AM EST
Read more
18
Feb
2020
16:30 E.S.T.
Cellectis and Servier Expand Collaboration on UCART19 Products
Read more
15
Jan
2020
16:30 E.S.T.
First Patient Dosed with Cellectis’ New Allogeneic UCART123 Product Candidate for Relapsed/Refractory Acute Myeloid Leukemia
Read more
Prev
1
2
3
4
5
Next